Glaucoma News and Research

Latest Glaucoma News and Research

DMEI dedicates new $46M research and clinical facility

Officials from the Dean McGee Eye Institute today announced the dedication of the Institute's new $46 million, five-story, 78,000-square-foot, world-class research and clinical facility.

1 Oct 2011

Many Canadians are not screening for glaucoma earlier, finds study

Glaucoma is the second leading cause of blindness worldwide. Although it can be treated, new research shows Canadians may not be doing enough to protect themselves. According to a new study by Lawson Health Research Institute's Dr. Cindy Hutnik, many Canadian glaucoma patients are not screened until the disease has reached moderate or advanced stages.

30 Sep 2011

Cocaine use linked to increased risk of open-angle glaucoma

A study of the 5.3 million men and women seen in Department of Veterans Affairs outpatient clinics in a one-year period found that use of cocaine is predictive of open-angle glaucoma, the most common type of glaucoma.

30 Sep 2011

Positive results from Clermont's non-preserved latanoprost phase III trial on glaucoma

Clermont Pharmaceuticals, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today positive results from a phase III trial of non-preserved latanoprost. In the study, non-preserved latanoprost was compared to Xalatan (latanoprost ophthalmic solution) 0.005%, in subjects diagnosed with open-angle glaucoma.

26 Sep 2011

IRIDEX licenses rights to Ocunetics' intellectual property

IRIDEX Corporation today announced that it has exclusively licensed the rights to all of the intellectual property of Ocunetics, Inc., a privately held company based in Alamo, California. Ocunetics develops procedure-enabling medical devices that are intended to increase surgeons' efficiency, while improving case predictability for ophthalmic surgeries.

21 Sep 2011

New collaboration reinforces Sanofi's translational discovery platform for retinal diseases

The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.

16 Sep 2011

CHAM experts available to discuss variety of back-to-school issues

Experts from The Children's Hospital at Montefiore (CHAM) are available for interviews on a variety of back-to-school issues.

16 Sep 2011

Amakem receives €18m in Series A round of funding

Amakem NV today announced it has raised €18m with a syndicate of leading life sciences investors to advance its ophthalmology drug development portfolio and progress its lead candidate, AMA0076 for glaucoma, to clinical proof of concept.

6 Sep 2011

Contraceptive pill prevents loss of eye sight

Scientists at University College Cork (UCC) have shown that the active component (Norgestrel) of the contraceptive 'Mini Pill' prevents the loss of sight in mice that have degenerative eye conditions that normally lead to blindness.

2 Sep 2011

Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe

Astellas Pharma Inc. today announced the submission of a New Drug Application and Market Authorisation Application for mirabegron to the U.S. Food and Drug Administration and the European Medicines Agency.

29 Aug 2011

Patients with diabetes, hypertension more likely to develop open-angle glaucoma

Many Americans suffer from diabetes and hypertension and, according to a study by researchers at the University of Michigan Kellogg Eye Center, these individuals may have an increased risk of developing open-angle glaucoma.

18 Aug 2011

HSS, pSivida enter orthopedic evaluation agreement

Drug delivery company pSivida Corp. today announced it has entered into an evaluation agreement with Hospital for Special Surgery (HSS), a world leader in orthopedics, rheumatology and rehabilitation, to investigate pSivida's drug delivery technologies in orthopedics.

17 Aug 2011

New endoscopic OCT system enables 3-D imaging of esophagus, colon cancers

Researchers at the Massachusetts Institute of Technology (MIT) have developed a new imaging system that enables high-speed, three-dimensional (3-D) imaging of microscopic pre-cancerous changes in the esophagus or colon.

2 Aug 2011

Early detection critical in preventing vision loss among Baby Boomers

Probably the most worrisome health concern for Baby Boomers as they age is the increased possibility of visual impairment or vision loss. For this reason, early detection is critical in successfully preventing and treating eye conditions such as macular degeneration, cataracts, glaucoma and diabetic retinopathy, before they lead to major visual changes.

27 Jul 2011

Allowing optometrists to perform surgeries may put patients at risk

Proposed regulations for a new state law which allows optometrists, who are not medical doctors, to perform a broad range of surgical procedures on the eye, fail to properly define the education, training and oversight necessary for this new scope of work that is typically performed by medical board-certified physicians.

22 Jul 2011

Inotek completes two stages of INO-8875 Phase 2b trial against glaucoma

Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.

22 Jul 2011

U.S. physicians to receive nearly $10M from Humana's Provider Quality Rewards Program

Humana Inc. has begun distributing nearly $10 million to physicians across the U.S. who participate in Humana's Provider Quality Rewards Program. Approximately 2,800 physician practices will receive payments of as much as $175,000 in recognition of performance improvements their practices made during 2010 related to improved outcomes for Humana's Medicare members.

21 Jul 2011

Retinal cells require vitamin C to function properly

Nerve cells in the eye require vitamin C in order to function properly - a surprising discovery that may mean vitamin C is required elsewhere in the brain for its proper functioning, according to a study by scientists at Oregon Health & Science University recently published in the Journal of Neuroscience.

16 Jul 2011

Study: Overall awareness about eye health lower among ethnic Americans

The results of recent, comprehensive research supported by Transitions Optical revealed that the majority of Americans are not taking the proper steps to care for the health of their eyes, and that awareness of both short- and long-term effects of UV exposure on vision is remarkably low.

15 Jul 2011

African-Americans with glaucoma have higher oxygen levels than Caucasians

Measuring oxygen during eye surgery, investigators at Washington University School of Medicine in St. Louis have discovered a reason that may explain why African-Americans have a higher risk of glaucoma than Caucasians.

12 Jul 2011